| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Immunology Division, Jichi Medical School, Minamikawachi-Machi, Tochigi-Ken 329-04
2 Japanese Red Cross Blood Center, Saitama-Ken 362
3 Hepatitis Division, The Tokyo Metropolitan Institute of Medical Science, Tokyo 113
and4 Institute of Immunology, Tokyo 112, Japan
The entire nucleotide sequence of genomic DNA was determined for hepatitis B virus (HBV) of subtype ayr, which had been derived from the blood of a Japanese asymptomatic carrier. The genome was 3215 nucleotides long, and differed in DNA sequence by 10% from that of subtypes adw or ayw, but by only 2% from that of subtype adr. Amino acid sequences coded for by the S, C, P and X genes, as well as by the pre-S region, closely resembled those of subtype adr, indicating that the evolution of HBV/ayr from HBV/adr was more recent than the differentiation of the other three subtypes. In the product of the S gene, the mutually exclusive subtypic determinants of the surface antigen, d and y, were associated with variation of amino acid residues at only the 68th and 122nd positions from the N terminus, in contrast to the variation at as many as seven positions for the other set of subtypic determinants, w and r. Sequences representing high local hydrophilicity in the product of the S gene were involved in subtypic variation, although such sequences in the pre-S region were shared by HBV genomes of the various subtypes. In particular, a hydrophilic sequence of 19 amino acid residues, coded for by the pre-S(2) region and implicated in the presumed hepatotropism of HBV, was possessed in common by HBV/adr, HBV/ayr and HBV/ayw, and differed in HBV/adw by only one residue at the 9th position. This amino acid sequence appears to be a promising candidate for a synthetic peptide vaccine.
Keywords: hepatitis B virus, subtypes, nucleotide sequence
Received 16 May 1986;
accepted 31 July 1986.
This article has been cited by other articles:
|
|
 |
|
  M. A. Bracho, M. J. Gosalbes, F. Gonzalez, A. Moya, and F. Gonzalez-Candelas Molecular Epidemiology and Evolution in an Outbreak of Fulminant Hepatitis B Virus J. Clin. Microbiol., April 1, 2006; 44(4): 1288 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Sall, S. Starkman, J. M. Reynes, S. Lay, T. Nhim, M. Hunt, N. Marx, and P. Simmonds Frequent infection of Hylobates pileatus (pileated gibbon) with species-associated variants of hepatitis B virus in Cambodia J. Gen. Virol., February 1, 2005; 86(2): 333 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Alexopoulou, G. Baltayiannis, S. Jammeh, J. Waters, S. P. Dourakis, and P. Karayiannis Hepatitis B Surface Antigen Variant with Multiple Mutations in the a Determinant in an Agammaglobulinemic Patient J. Clin. Microbiol., June 1, 2004; 42(6): 2861 - 2865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cui, J. Shi, L. Hui, H. Xi, Zhuoma, Quni, Tsedan, and G. Hu The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid J. Gen. Virol., November 1, 2002; 83(11): 2773 - 2777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sugauchi, M. Mizokami, E. Orito, T. Ohno, H. Kato, S. Suzuki, Y. Kimura, R. Ueda, L. A. Butterworth, and W. G. E. Cooksley A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness J. Gen. Virol., April 1, 2001; 82(4): 883 - 892. [Abstract] [Full Text]
|
|
|
|
|
|
T. Chen, J. M. Luk, S.-T. Cheung, W.-C. Yu, and S.-T. Fan Evaluation of Quantitative PCR and Branched-Chain DNA Assay for Detection of Hepatitis B Virus DNA in Sera from Hepatocellular Carcinoma and Liver Transplant Patients J. Clin. Microbiol., May 1, 2000; 38(5): 1977 - 1980. [Abstract] [Full Text]
|
|
|
|
|
|
C. Hannoun, P. Horal, and M. Lindh Long-term mutation rates in the hepatitis B virus genome J. Gen. Virol., January 1, 2000; 81(1): 75 - 83. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Nakao, K. Nakata, M. Yamashita, Y. Tamada, K. Hamasaki, H. Ishikawa, Y. Kato, K. Eguchi, and N. Ishii p48 (ISGF-3gamma ) Is Involved in Interferon-alpha -induced Suppression of Hepatitis B Virus Enhancer-1 Activity J. Biol. Chem., October 1, 1999; 274(40): 28075 - 28078. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
